XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation

AIMS: Although non-vitamin K antagonist oral anticoagulants are recommended for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) based on clinical trial results, there is a need for safety and efficacy data from unselected patients in everyday clinical practice. XANTUS inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Camm, A. John, Amarenco, Pierre, Haas, Sylvia, Hess, Susanne, Kirchhof, Paulus, Kuhls, Silvia, van Eickels, Martin, Turpie, Alexander G.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
FASTTRACK ESC Clinical Registry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823634/
https://www.ncbi.nlm.nih.gov/pubmed/26330425
http://dx.doi.org/10.1093/eurheartj/ehv466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823634/
https://www.ncbi.nlm.nih.gov/pubmed/26330425
http://dx.doi.org/10.1093/eurheartj/ehv466

Ejemplares similares